NFKB1 and Miyoshi myopathy: Similarly, a neutralizing antibody against IGF-1 receptor, whose ligation by IGF-1 has been shown to activate NF-κB in certain MM samples [29], had no effect on BMSC-induced NF-κB activity in RPMI8226 cells (Additional File 3B).